[{"from": "human", "value": "Please give me some details about this molecule. [C][=C][C][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][C][=N][C][Branch2][Ring1][Ring1][C][=Branch1][C][=O][N][C][=C][Ring1][Branch2][C][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][Cl][O]"}, {"from": "gpt", "value": "The molecule is an intermediate-acting, 3-hydroxybenzodiazepine used in the treatment of alcohol withdrawal and anxiety disorders. Oxazepam, like related 3-hydroxybenzodiazepine [lorazepam], is considered less susceptible to pharmacokinetic variability based on patient-specific factors (e.g. age, liver disease) - this feature is advantageous as compared to other benzodiazepines, and is likely owing in part to oxazepam's relatively simple metabolism. It is an active metabolite of both [diazepam] and [temazepam] and undergoes very little biotransformation following absorption, making it unlikely to participate in pharmacokinetic interactions."}]